MHRA-102010-PIP01-25

Key Facts

Active Substance
Active Substance:
  • PEGCETACOPLAN
Invented Name
  • Syfovre
  • Syfovre
  • Syfovre
  • Syfovre
PIP Number MHRA-102010-PIP01-25
Pharmaceutical form(s)
Pharmaceutical form(s):
  • Solution for injection
Therapeutic area
Therapeutic area:
  • Ophthamology
Conditions / Indications
Conditions / Indications:
  • Treatment of geographic atrophy secondary to age related macular degeneration.
Route(s) of administration
Route(s) of administration:
  • Intravitreal use
PIP applicant
  • Apellis UK Limited
  • Country United Kingdom
  • Tel +16179775700
  • Email info@apellis.com
Decision Type
Decision Type
W: decision granting a waiver in all age groups for the listed condition(s).
Compliance Check
Compliance Check
No
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

Decision Document Decision Document on a Paediatric Investigation Plan (PIP):PEGCETACOPLAN.pdf
Published Date 30/07/2025